pioneer 7 semaglutide Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial semaglutide articles Efficacy and safety

Department of Periodontology and Oral Medicine, University of Limpopo, Medunsa Campus, South Africa ACRONYMS aMSH: alpha melanocyte stimulating hormone HAART: highly active antiretroviral therapy MC1R: melanocortin 1 receptor OMH: Oral melanin hyperpigmentation HIV-OMH: HIV associated oral melanin hyperpigmentation INTRODUCTION Oral melanin hyperpigmentation (OMH) is not uncommon in HIV+ persons 1 In Venezuela (38%) 5 and in India (30%) 3 HIV-associated OMH (HIV-OMH) is quite common, but by contrast is substantially less common in Italy (6.4%) 4 and in sub-Saharan Africa (Tanzania, 4.7%, Kenya, 6%)

Pharmacological Reports, 73 , 1020

Because these products have different approved uses, dosage forms, strengths and costs, it's important to review them with your healthcare provider before use

Acquisitions are adding further pipeline depth and long-term optionality

MORE Discover our 7 locations from Italy to China, from France to the USA